COMMUNIQUÉS West-GlobeNewswire

Eric Palmer Joins AMN Healthcare Board of Directors
13/05/2026
DALLAS, May 13, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announced the election of Eric Palmer to its Board of Directors, effective May 1 [...]
Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
13/05/2026
First-in-human study evaluates weekly IV Sapu003 in advanced mTOR-sensitive solid tumors, including HR+/HER2- breast cancer, RCC, NETs, TSC-associated tumors, and HCC SAN DIEGO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- [...]
USOSM Secures Partnership with Hudson Valley Oral Surgery
13/05/2026
IRVING, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial surgeons –has secured a new partnership [...]
Noted Vaccine Researchers Uğur Şahin and Özlem Türeci Awarded Sabin Vaccine Institute’s Albert B. Sabin Gold Medal; Genomic Scientist Senjuti Saha of Bangladesh Receives Rising Star Award
13/05/2026
WASHINGTON, May 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Sabin Awards were presented yesterday at the National Academy of Sciences building in Washington, D.C., with Professor Uğur Şahin, MD, and Professor Özlem Türeci, MD [...]
Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial
13/05/2026
Raanana, Israel, May 13, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
SafeSpace Global Corp. (OTCID: SSGC) to Participate in Nashville AI Week; President & CSO Dustin Hillis Scheduled for Multiple Speaking Engagements
13/05/2026
Knoxville, TN., May 13, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation ("SafeSpace" or the "Company") (OTCID: SSGC), a provider of multimodal AI-powered physical safety and security technologies designed to [...]
The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer
13/05/2026
The World’s Plastic Addiction Is Becoming an Economic and Environmental Disaster, and Biomaterials could become the Ultimate Replacement DENVER, May 13, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com ) – The global [...]
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
13/05/2026
Company Remains on Track For Design Freeze by End of Year 2026 WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform [...]
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
13/05/2026
CINCINNATI, May 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, at [...]
Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
13/05/2026
The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day This social media–driven initiative invites people to wear a hat, share a photo, and help raise [...]
Neomorph Appoints Biopharma Leader Robert J. Hugin as Chairman of the Board
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc. , a biotechnology company advancing a new class of molecular glue degraders to target historically undruggable proteins, today announced the appointment of Bob [...]
Sharecare joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
13/05/2026
American Heart Association consortium advances development of evidence-based health tech solutions ATLANTA, May 13, 2026 (GLOBE NEWSWIRE) -- Sharecare, the digital health enablement company that helps to improve care [...]
Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study
13/05/2026
New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion Advances CINCINNATI [...]
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
13/05/2026
Appointment Supports Commercialization of Newly Launched BIONX Surgical Division, Formed Through Transformative Acquisition Expected to Significantly Scale Revenue LANGHORNE, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- NEXGEL [...]
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
13/05/2026
Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its European center of [...]
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
13/05/2026
Company has invested over 10 % of its investable capital in Artificial Intelligence (“AI”) and space through Astro Capital NORTH PALM BEACH, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE [...]
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
13/05/2026
Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, representing 66% of quarterly sales Nine-month revenue reaches $3.07 million, up 39% year-over-year, building on record first [...]
Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
13/05/2026
Enrollment on track for Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis patients with topline results anticipated in 1H27 Enrollment ongoing for Phase 3 UPSTREAM SjD of telitacicept in primary [...]
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
13/05/2026
WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF [...]

Pages